3-[2-amino-6-[1-[(6-ethyl-2-pyridinyl)methyl]triazol-4-yl]pyrimidin-4-yl]-5-chlorobenzonitrile
C21H17ClN8 — CID 135272726
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-[2-amino-6-[1-[(6-ethyl-2-pyridinyl)methyl]triazol-4-yl]pyrimidin-4-yl]-5-chlorobenzonitrile
3-[2-amino-6-[1-[(6-ethyl-2-pyridinyl)methyl]triazol-4-yl]pyrimidin-4-yl]-5-chlorobenzonitrile (PubChem CID 135272726) has the molecular formula C21H17ClN8 and a molecular weight of 416.88 g/mol. Its IUPAC name is 3-[2-amino-6-[1-[(6-ethyl-2-pyridinyl)methyl]triazol-4-yl]pyrimidin-4-yl]-5-chlorobenzonitrile.
Molecular Properties
| Compound Name | 3-[2-amino-6-[1-[(6-ethyl-2-pyridinyl)methyl]triazol-4-yl]pyrimidin-4-yl]-5-chlorobenzonitrile |
|---|---|
| PubChem CID | 135272726 |
| Molecular Formula | C21H17ClN8 |
| Molecular Weight | 416.88 g/mol |
| Exact Mass | 416.13 |
| IUPAC Name | 3-[2-amino-6-[1-[(6-ethyl-2-pyridinyl)methyl]triazol-4-yl]pyrimidin-4-yl]-5-chlorobenzonitrile |
| SMILES | CCc1cccc(Cn2cc(-c3cc(-c4cc(Cl)cc(C#N)c4)nc(N)n3)nn2)n1 |
| InChI | InChI=1S/C21H17ClN8/c1-2-16-4-3-5-17(25-16)11-30-12-20(28-29-30)19-9-18(26-21(24)27-19)14-6-13(10-23)7-15(22)8-14/h3-9,12H,2,11H2,1H3,(H2,24,26,27) |
| InChIKey | IRNXTJWKJBWZKR-UHFFFAOYSA-N |
| XLogP | 3.52 |
| TPSA | 119.19 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 416.88 |
| LogP ≤ 5 | 3.52 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 135272726 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.